Immunogenicity and Therapeutic Targeting of Recurrently Mutated "Public" Neoantigens

Поділитися
Вставка
  • Опубліковано 1 гру 2024
  • A Mount Sinai Department of Medicine Grand Rounds presented by Christopher A. Klebanoff, MD, Memorial Sloan Kettering, Center for Cell Engineering

КОМЕНТАРІ •